Navigation Links
Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
Date:10/20/2013

in patients with lung cancer. They then showed that PF-06463922 inhibited the growth of tumors harboring three of the crizotinib-resistant ALK mutants, including the most resistant ALK mutant, G1202R, in mice.

Further analysis indicated that PF-06463922 readily entered the brains of mice, rats, and dogs. In mice, levels of PF-06463922 in the brain were 20-30 percent of levels of PF-06463922 in the blood. This is potentially clinically relevant because a significant number of lung cancer patients will develop brain metastasis during the course of their disease, according to Smeal, although he noted that it will be important to see if these results in animals hold true in humans.

Smeal and colleagues also found that PF-06463922 potently inhibited the protein ROS1, a close relative of ALK recently implicated in a number of cancer types, including some lung and brain cancers. Further, PF-06463922 had antitumor effects in two mouse models of cancers driven by ROS1 gene abnormalities, leading the researchers to suggest that PF-06463922 has potential as a treatment for this subgroup of cancers, in addition to its promise as a new treatment for ALK-driven cancers.


'/>"/>

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Targeted therapeutics for colon cancer to be presented at AACR meeting
2. First targeted nanomedicine to enter human clinical studies
3. Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer
4. Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
5. Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment
6. Killer infections targeted by hospital study
7. Lower risk of serious side-effects in trials of new targeted drugs
8. Treating drug resistant cancer through targeted inhibition of sphingosine kinase
9. Pitt: Targeted oxidation-blocker prevents secondary damage after traumatic brain injury
10. Deadly witch hunts targeted by grassroots womens groups
11. Large lung cancer study shows potential for more targeted therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... of all lung cancers are small cell lung ... resistance to chemotherapy. However, researchers at Virginia Commonwealth ... into the mechanisms leading to this resistance that ... work primarily by mediating B-cell lymphoma 2 (Bcl-2) ... death. Depending on their function, this family of ...
(Date:4/22/2014)... The International Communication Association will hold its ... The theme of the 2014 conference will explore ... and digital society. , Featuring over 2,300 academic ... Communication scholars representing over 40 countries, the ICA ... in the world. This year,s conference features sessions ...
(Date:4/22/2014)... release is available in German . ... important intracellular signaling molecules, but their mode of action ... of cellular function and behavior, while at high concentrations ... and DNA. To analyze how redox signaling unfolds in ... microscopy technique has been developed jointly by the teams ...
(Date:4/22/2014)... (SALT LAKE CITY)A computational tool developed at the University ... with unknown gene mutations in three separate cases, U ... new study in The American Journal of Human ... Re-ranking tool), identifies undiagnosed illnesses and unknown gene mutations ... proteins that code for genes are made, in individual ...
(Date:4/22/2014)... demonstrated the first size-based form of chromatography that ... living cells. This unique physical approach to probing ... whether a cell lives or dies, remains normal ... conventional microscopy. , "We,ve developed membrane-embedded nanodot array ... probe and manipulate membrane assemblies, including signaling clusters, ...
Breaking Medicine News(10 mins):Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:Neuroimaging: Live from inside the cell 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3
... 8 ChildCare Education Institute (CCEI), a distance training institution ... give professional development training hours to ... child care providers can log in to CCEI,s learning management ... 2009 and May 15th, 2009 and receive five (5) hours ...
... Income Rises 172% to Record $2.3 MillionCHICAGO, May 8 Second quarter highlights: , ... Increase to $2.3 Million , Gross Profit Margin ... 46% Gross Profit Increase , ... , Year-to-date highlights: , , , ...
... Valeant Pharmaceuticals International (NYSE: VRX ) ... held company located in Poland for approximately $28 million. ... Poland into multiple therapeutic categories. EMO-FARM has a strong ... portfolio of currently marketed products and additional products under ...
... Ohio, May 8 James "Buster" Douglas, former ... President Obama in his brand new inspirational diabetic ... said, in "Buster,s Backyard Bar-B-Q Knockout Diabetes Diet," ... Kindle versions in time to order for Mother,s ...
... During May,s "National Brain Tumor Awareness Month"WASHINGTON, May 8 ... the sad news of his brother,s death from a brain ... of loss -- over 200,000 people will be diagnosed with ... an effort to bring awareness and ultimately find a cure, ...
... have less cardiovascular disease than those who smoke, ... men and women in Norway. Smoking, say the ... mortality from various causes. , The results, presented ... other studies have indicated, but, says investigator Professor ...
Cached Medicine News:Health News:ChildCare Education Institute Gives Child Care Staff Access to Professional Development Courses in Honor of Provider Appreciation Day, May 8th 2Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 2Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 3Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 4Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 5Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 6Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 7Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 8Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 9Health News:Valeant to Acquire Polish Dermatology Company 2Health News:President Obama's New Knockout Mother's Day Message from Champ 2Health News:Grey Ribbon Crusade(TM) Promotes National Unification in the Fight Against Brain Tumors 2Health News:30-year follow-up study: 'Tremendous' impact of smoking on mortality and cardiovascular disease 2
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy....
... Sysmex CA-7000 provides speed and precision ... synonymous with Sysmex technology. With ... throughput of up to 300 samples ... multi-parameter testing. This high performance, ...
... CA-1500 enhances productivity in the laboratory with ... detection methods clotting, chromogenic and immunological ... precise test results every time. With ... and random access, the CA-1500 will provide ...
... is the lancing device that has set ... since 1983. This re-usable lancing device assists ... The auto-Lancet is constructed in the USA ... after day, year after year. It's the ...
Medicine Products: